Home | About PR | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions | Subscribe | Advertise | Contact us |   Login 
Pharmacognosy Magazine
Search Article 
  
Advanced search 
 
ORIGINAL ARTICLE
Year : 2020  |  Volume : 12  |  Issue : 1  |  Page : 71-75

Ghanaian herbal medicines for malaria: An Evaluation of the Clinical Safety and Effectiveness of “Time Herbal Mixture” in uncomplicated malaria


1 Herbal Medicine Unit, Kumasi South Hospital, Ghana Health Service, Ghana
2 Department of Herbal Medicine, Faculty of Pharmacy and Pharmaceutical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana
3 Department of Maternal and Child Health, Kumasi South Hospital, Cape Coast, Ghana
4 Department of Biomedical Sciences, University of Cape Coast, Cape Coast, Ghana
5 Department of Pharmacognosy, Faculty of Pharmacy and Pharmaceutical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana
6 Herbal Medicine Unit, Tafo Government Hospital, Ghana Health Service, Kumasi, Ghana
7 Department of Pharmacy, Kumasi South Hospital, Ghana Health Service, Kumasi, Ghana
8 Department of Mathematics, Faculty of Physical and Computational Sciences, College of Science Kwame Nkrumah University of Science and Technology, Kumasi, Ghana

Correspondence Address:
Mr. Andrews W. Tetteh
Herbal Medicine Unit, Kumasi South Hospital, Ghana Health Service, Kumasi
Ghana
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/pr.pr_23_19

Rights and Permissions

Background: Herbal antimalarials have become a popular source of treatment for most Ghanaians. The significant increase in patronage is of public health concern due to the lack of quality, safety, and efficacy data. Aim: In this report, we evaluated the clinical safety and effectiveness of a Ghanaian commercial product named “Time Herbal Mixture” (THM). The product is formulated from the leaves of Solanum torvum and Vernonia amygdalina and the stem bark of Spathodea campanulata and Bombax buonopozense. Methods: Participants of 40 patients diagnosed with uncomplicated malaria were recruited, treated, and followed up for a period of 28 days. This population comprised 25 (62.50%) females and 15 (37.50%) males, with a mean age of 42.29 (12.35) years. Outcome of primary interest was the ability of the product to clear blood parasites by day 7 of the study, resolution of cardinal symptoms of malaria, and an absence of adverse effects from the use of the product. Results and Discussion: A total of 33 (82.50%) participants achieved clearance of all parasites by day 7 (complete cure). Partial clearance was attained by 6 (15.0%) and treatment failure in 1 (2.50%). Resolution of the cardinal symptoms was also observed in most participants by day 7. The product also had a good safety profile as none of the participants reported any adverse effects. Liver, kidney, and hematological profiles were also normal after the study. Conclusion: THM,” therefore, has the potential to be used in cases of uncomplicated malaria.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed242    
    Printed6    
    Emailed0    
    PDF Downloaded35    
    Comments [Add]    

Recommend this journal